Single pivotal trials with few corroborating characteristics were used for FDA approval of cancer therapies by Aviv, L, Speich, B, Matthias, B, Francesco, S, Heiner C, B, Arnav, A, John P.A., I, Tiago V., P, Benjamin, K, Lars G, H